Effect of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on cardiovascular outcomes in dialysis patients: a systematic review and meta-analysis

ABSTRACT Background Angiotensin-converting enzyme inhibitors (ACEIs) and/or angiotensin receptor blockers (ARBs) are recommended by guidelines as first-line antihypertensive therapies in the general population or in patients with earlier stages of kidney disease. However, the cardioprotective benefi...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Nephrology, dialysis, transplantation dialysis, transplantation, 2023-01, Vol.38 (1), p.203-211
Hauptverfasser:	Georgianos, Panagiotis I, Tziatzios, Georgios, Roumeliotis, Stefanos, Vaios, Vasilios, Sgouropoulou, Vasiliki, Tsalikakis, Dimitrios G, Liakopoulos, Vassilios, Agarwal, Rajiv
Format:	Artikel
Sprache:	eng
Schlagworte:	Angiotensin Receptor Antagonists - therapeutic use Angiotensin-Converting Enzyme Inhibitors - therapeutic use Antihypertensive Agents - therapeutic use Humans Hypertension - drug therapy Renal Dialysis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!